Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT201) in the Treatment of Advanced Gynecological Tumors

NCT06834542 is registered in ClinicalTrials.gov with Grit Biotechnology as lead sponsor.

NCT NCT06834542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT201) in the Treatment of Advanced Gynecological Tumors
Lead sponsor
Grit Biotechnology
Phase
Phase 1
Overall status
Terminated
Start date
November 1, 2022
Completion date
December 30, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult gynecological tumors